홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,4-Diazabicyclo(2.2.2)octane--trimethylalumane (1/2) → 2-N-Methyl-2-N-phenyl-6-{5-[(4-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}piperidin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,3,5-triazine-2,4-diamine

HRID 341449
인쇄

반응식

HRID 341449 반응식
C[Al](C)C.C[Al](C)C.C1N2CCN(CC2)C1.Cl.[F:18][C:19]([F:30])([F:29])[CH2:20][S:21][CH2:22][CH:23]1[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]1.[NH2:31][C:32]1[N:37]=[C:36]([N:38]([CH3:45])[C:39]2[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=2)[N:35]=[C:34]([C:46]2[N:50]=[C:49]([C:51](OCC)=[O:52])[O:48][N:47]=2)[N:33]=1>C1COCC1>[CH3:45][N:38]([C:39]1[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=1)[C:36]1[N:37]=[C:32]([NH2:31])[N:33]=[C:34]([C:46]2[N:50]=[C:49]([C:51]([N:26]3[CH2:27][CH2:28][CH:23]([CH2:22][S:21][CH2:20][C:19]([F:29])([F:18])[F:30])[CH2:24][CH2:25]3)=[O:52])[O:48][N:47]=2)[N:35]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 166883661,4-Diazabicyclo(2.2.2)octane--trimethylalumane (1/2)HCID 668028784-{[(2,2,2-Trifluoroethyl)sulfanyl]methyl}piperidine hydrochloride2회HCID 66803067Ethyl 3-{4-amino-6-[methyl(phenyl)amino]-1,3,5-triazin-2-yl}-1,2,4-oxadiazole-5-carboxylate

생성물 1

HCID 668031492-N-Methyl-2-N-phenyl-6-{5-[(4-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}piperidin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,3,5-triazine-2,4-diamine
수율 11%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

Bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]octane adduct (225 mg, 0.88 mmol) was added to 4-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}piperidine hydrochloride (Intermediate 267, 219 mg, 0.88 mmol) in dry THF (6 mL) in a sealed tube at room temperature. The reaction mixture was stirred at 40 C for 2 h. Ethyl 3-{4-amino-6-[methyl(phenyl)amino]-1,3,5-triazin-2-yl}-1,2,4-oxadiazole-5-carboxylate (prepared in an analogous manner to Example 73, 200 mg, 0.58 mmol) was added at 40 C. The reaction was heated at 80 C for 2 h before being concentrated under vacuum. The residue was taken up in DMSO (6 mL) and the inorganic residue was filtered off. The filtrate was purified by preparative HPLC, Method C, to provide two batches of the title compound (batch 1: 33 mg, 11%). Some impure product was recovered from the preparative HPLC purification, this material was concentrated, diluted with water (50 mL), acidified with a 1N aq. solution of HCl (to pH 4) and extracted with EtOAc (3×50 mL). The combined organic layers were washed with brine (50 mL) and dried over magnesium sulfate. This crude material was then purified by preparative HPLC, Method C, to provide the title compound (Batch 2: 83 mg, 28%).

후처리

  1. additionwas added at 40 C
  2. temperatureThe reaction was heated at 80 C for 2 h
  3. concentrationbefore being concentrated under vacuum
  4. filtrationthe inorganic residue was filtered off
  5. customThe filtrate was purified by preparative HPLC, Method C

출처 및 근거

ORD 기록
ord-74ecfa6718914b858144cdf6b5febd1c
출처 데이터셋
uspto-grants-2014_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08895733B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트